RRC ID 58899
Author Romano M, Frapolli R, Zangarini M, Bello E, Porcu L, Galmarini CM, García-Fernández LF, Cuevas C, Allavena P, Erba E, D'Incalci M.
Title Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).
Journal Int J Cancer
Abstract This study: (i) investigated the in vitro cytotoxicity and mode of action of lurbinectedin (PM01183) and Zalypsis® (PM00104) compared with trabectedin in cell lines deficient in specific mechanisms of repair, (ii) evaluated their in vivo antitumor activity against a series of murine tumors and human xenografts. The antiproliferative activity, the DNA damage and the cell cycle perturbations induced by the three compounds on tumor lines were very similar. Nucleotide Excision Repair (NER) deficient cells were approximately fourfold more resistant to trabectedin, lurbinectedin and Zalypsis®. Cells deficient in non-homologous end joining (NHEJ), MRN complex and translesion synthesis (TLS) were slightly more sensitive to the three compounds (approximately fivefold) while cells deficient in homologous recombination (HR) were markedly more sensitive (150-200-fold). All three compounds showed a good antitumor activity in several in vivo models. Lurbinectedin and trabectedin had a similar pattern of antitumor activity in murine tumors and in xenografts, whereas Zalypsis® appeared to have a distinct spectrum of activity. The fact that no relationship whatsoever was found between the in vitro cytotoxic potency and the in vivo antitumor activity, suggests that in addition to direct cytotoxic mechanisms other host-mediated effects are involved in the in vivo pharmacological effects.
Volume 133(9)
Pages 2024-33
Published 2013-11-1
DOI 10.1002/ijc.28213
PMID 23588839
MeSH Alkaloids / pharmacology Animals Antineoplastic Agents, Alkylating / pharmacology Apoptosis / drug effects Carbolines / pharmacology* Cell Cycle / drug effects Cell Proliferation / drug effects Cells, Cultured Chickens DNA Damage / drug effects* DNA Repair / drug effects* Dioxoles / pharmacology* Flow Cytometry Heterocyclic Compounds, 4 or More Rings / pharmacology* Humans In Vitro Techniques Mice Mice, Inbred C57BL Mice, Nude Molecular Structure Neoplasms / drug therapy* Neoplasms / pathology Tetrahydroisoquinolines / pharmacology* Trabectedin Xenograft Model Antitumor Assays
IF 5.145
Resource
Human and Animal Cells DT40 Library